- Home
- MEI vs KOD Comparison
MEI vs KOD Comparison
Compare MEI & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEI
- KOD
- Stock Information
- Founded
- MEI 1946
- KOD 2009
- Country
- MEI United States
- KOD United States
- Employees
- MEI N/A
- KOD N/A
- Industry
- MEI Electrical Products
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MEI Technology
- KOD Health Care
- Exchange
- MEI Nasdaq
- KOD Nasdaq
- Market Cap
- MEI 464.2M
- KOD 454.7M
- IPO Year
- MEI N/A
- KOD 2018
- Fundamental
- Price
- MEI $10.53
- KOD $4.45
- Analyst Decision
- MEI Hold
- KOD Hold
- Analyst Count
- MEI 3
- KOD 4
- Target Price
- MEI $14.00
- KOD $8.00
- AVG Volume (30 Days)
- MEI 249.3K
- KOD 347.2K
- Earning Date
- MEI 03-05-2025
- KOD 03-27-2025
- Dividend Yield
- MEI 5.32%
- KOD N/A
- EPS Growth
- MEI N/A
- KOD N/A
- EPS
- MEI N/A
- KOD N/A
- Revenue
- MEI $1,087,900,000.00
- KOD N/A
- Revenue This Year
- MEI N/A
- KOD N/A
- Revenue Next Year
- MEI $5.40
- KOD N/A
- P/E Ratio
- MEI N/A
- KOD N/A
- Revenue Growth
- MEI N/A
- KOD N/A
- 52 Week Low
- MEI $8.54
- KOD $2.19
- 52 Week High
- MEI $21.86
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- MEI 42.20
- KOD 27.56
- Support Level
- MEI $9.69
- KOD $4.85
- Resistance Level
- MEI $10.84
- KOD $5.53
- Average True Range (ATR)
- MEI 0.47
- KOD 0.39
- MACD
- MEI -0.01
- KOD -0.05
- Stochastic Oscillator
- MEI 55.26
- KOD 1.03
About MEI Methode Electronics Inc.
Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.